Physical Activity in Adults with Severe Asthma On-Treatment with Biological Therapies: A 1-Year Retrospective Analysis of Real-World Data [0.03%]
生物治疗成人重度哮喘患者中的体育活动：一项为期一年的现实世界数据回顾性分析
Caroline Reilly,Antonios Stavropoulos-Kalinoglou,Daniel Peckham et al.
Caroline Reilly et al.
Introduction: Asthma is a complex airways disease that affects over 350-million people worldwide. It is estimated that up to 10% of adults and 2.5% of children with asthma have severe disease, which is associated with red...
Diagnostic Delays and Quality of Life in Japanese Patients with Pulmonary Hypertension: A Nationwide Survey [0.03%]
日本肺动脉高压患者诊断延迟与生活质量的全国性调查
Noriko Murakami,Daiki Asano,Natsuko Tokushige et al.
Noriko Murakami et al.
Introduction: Pulmonary hypertension (PH) is a rare and severe disorder that significantly affects patients' lives. However, a comprehensive picture of the diagnosis and treatment of this condition in Japan remains unclea...
A Brief Report on a Systematic Review of Real-World Effectiveness Studies of ICS/LAMA/LABA for Treatment of Adults with Asthma in the US [0.03%]
ICS/LAMA/LABA治疗美国成人哮喘的现实效果研究系统回顾简报
Stephen G Noorduyn,Kejsi Begaj,Amber Martin et al.
Stephen G Noorduyn et al.
Introduction: Long-acting muscarinic antagonist (LAMA) addition to inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) dual therapy is recommended for severe asthma, but its real-world effectiveness is not well esta...
Correction: Expert Panel Consensus Recommendations for Allergic Rhinitis in Patients with Asthma in India [0.03%]
校正：印度哮喘患者变应性鼻炎专家小组共识推荐意见
R Narasimhan,Sitesh Roy,Meghanadh Koralla et al.
R Narasimhan et al.
Published Erratum
Pulmonary therapy. 2025 Feb 18. DOI:10.1007/s41030-024-00283-x 2025
Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: Impact on Hospitalizations and Health Care Resource Utilization in a Universal Health Care Setting [0.03%]
Elexacaftor/Tezacaftor/Ivacaftor 治疗囊性纤维化：在全民医疗制度中的住院和卫生资源利用影响分析
Hans Kristian Råket,Mikkel Zöllner Ankarfeldt,Joanna Nan Wang et al.
Hans Kristian Råket et al.
Introduction: Elexacaftor/tezacaftor/ivacaftor (ETI) has been shown to substantially improve clinical outcomes among people living with cystic fibrosis (pwCF). The impact of ETI on health care resource utilization in the ...
Retrospective Cohort Study of Elderly Users of Single- or Multiple-Inhaler Triple Therapy for the Treatment of Asthma in the USA [0.03%]
美国单用或联用吸入三联疗法治疗哮喘老年人疗效的队列研究回顾性分析
Russell A Settipane,Guillaume Germain,Francois Laliberté et al.
Russell A Settipane et al.
Introduction: Escalation to single- or multiple-inhaler triple therapy (SITT; MITT) is a recommended option for patients with asthma who remain uncontrolled by medium-dose inhaled corticosteroid/long-acting β2-agonist; h...
Prevalence of Obstructive Sleep Apnea in Vietnamese Children with Attention Deficit Hyperactivity Disorder (ADHD) [0.03%]
注意缺陷多动障碍（ADHD）越南儿童阻塞性睡眠呼吸暂停的患病率
Mai Nguyen-Thi-Phuong,Mai Nguyen-Thi-Thanh,Thuy Nguyen-Thi-Dieu et al.
Mai Nguyen-Thi-Phuong et al.
Introduction: Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder among children with attention deficit hyperactivity disorder (ADHD). This study aims to determine the prevalence of OSA in children ...
Overlap Syndrome (COPD and OSA): A Treatable Trait for Triple Treatment? [0.03%]
重叠综合征（COPD和OSA）：三联治疗的可治疗特征？
Athanasios Voulgaris,Alexandros Kalkanis,Paschalis Steiropoulos
Athanasios Voulgaris
The coexistence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) in the same patient is referred to as overlap syndrome (OS). Patients with OS suffer more frequently from cardiovascular disease (CVD) and car...
Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19 [0.03%]
贝特洛维玛bin与尼马曲韦/利托那韦片组合包装治疗新冠肺炎门诊患者的有效性：队列研究
Christopher G Rowan,Russell M Nichols,Neil Dhopeshwarkar et al.
Christopher G Rowan et al.
Introduction: This real-world study assessed the effectiveness of bebtelovimab (BEB) versus nirmatrelvir/ritonavir (NR) among outpatients with COVID-19 during the Omicron variant era. ...
High Interleukin (IL)-6 is Associated with Lower Lung Function and Increased Likelihood of Metabolic Dysfunction in Asthma [0.03%]
高水平白细胞介素(IL)-6与哮喘患者较低的肺功能和增加的代谢紊乱风险相关
Dionne Adair,AmirBehzad Bagheri,Matheos Yosef et al.
Dionne Adair et al.
Introduction: Asthma is a complex condition characterized by airway inflammation. Interleukin-6 (IL-6) plays a significant role in asthma pathogenesis through its effects on T cells and its association with pro-inflammato...